A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours

BACKGROUND: Poly adenosine diphosphate (ADP)-ribose polymerase (PARP) is essential in cellular processing of DNA damage via the base excision repair pathway (BER). The PARP inhibition can be directly cytotoxic to tumour cells and augments the anti-tumour effects of DNA-damaging agents. This study ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, O A, Gore, M, Lorigan, P, Stone, J, Greystoke, A, Burke, W, Carmichael, J, Watson, A J, McGown, G, Thorncroft, M, Margison, G P, Califano, R, Larkin, J, Wellman, S, Middleton, M R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048218/
https://www.ncbi.nlm.nih.gov/pubmed/21326243
http://dx.doi.org/10.1038/bjc.2011.8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048218/
https://www.ncbi.nlm.nih.gov/pubmed/21326243
http://dx.doi.org/10.1038/bjc.2011.8

Ejemplares similares